171 related articles for article (PubMed ID: 12789289)
1. Role and regulation of the thrombin receptor (PAR-1) in human melanoma.
Tellez C; Bar-Eli M
Oncogene; 2003 May; 22(20):3130-7. PubMed ID: 12789289
[TBL] [Abstract][Full Text] [Related]
2. Regulation of gene expression in melanoma: new approaches for treatment.
Leslie MC; Bar-Eli M
J Cell Biochem; 2005 Jan; 94(1):25-38. PubMed ID: 15523674
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1.
Hazarika P; McCarty MF; Prieto VG; George S; Babu D; Koul D; Bar-Eli M; Duvic M
Cancer Res; 2004 Oct; 64(20):7361-9. PubMed ID: 15492257
[TBL] [Abstract][Full Text] [Related]
4. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers.
Schewe DM; Biller T; Maurer G; Asangani IA; Leupold JH; Lengyel ER; Post S; Allgayer H
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8538-48. PubMed ID: 16361535
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of melanoma metastasis.
Bar-Eli M
J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
[TBL] [Abstract][Full Text] [Related]
6. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
7. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H
Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470
[TBL] [Abstract][Full Text] [Related]
9. Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma.
Tellez C; McCarty M; Ruiz M; Bar-Eli M
J Biol Chem; 2003 Nov; 278(47):46632-42. PubMed ID: 12975361
[TBL] [Abstract][Full Text] [Related]
10. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers.
Schewe DM; Leupold JH; Boyd DD; Lengyel ER; Wang H; Gruetzner KU; Schildberg FW; Jauch KW; Allgayer H
Clin Cancer Res; 2003 Jun; 9(6):2267-76. PubMed ID: 12796395
[TBL] [Abstract][Full Text] [Related]
12. Gene regulation in melanoma progression by the AP-2 transcription factor.
Bar-Eli M
Pigment Cell Res; 2001 Apr; 14(2):78-85. PubMed ID: 11310795
[TBL] [Abstract][Full Text] [Related]
13. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
14. Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor.
Bromberg ME; Bailly MA; Konigsberg WH
Thromb Haemost; 2001 Nov; 86(5):1210-4. PubMed ID: 11816709
[TBL] [Abstract][Full Text] [Related]
15. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.
Maurer GD; Leupold JH; Schewe DM; Biller T; Kates RE; Hornung HM; Lau-Werner U; Post S; Allgayer H
Clin Cancer Res; 2007 Feb; 13(4):1123-32. PubMed ID: 17317820
[TBL] [Abstract][Full Text] [Related]
16. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130.
Mitchell DC; Stafford LJ; Li D; Bar-Eli M; Liu M
Oncogene; 2007 Mar; 26(12):1739-47. PubMed ID: 16964286
[TBL] [Abstract][Full Text] [Related]
18. Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.
Berger AJ; Davis DW; Tellez C; Prieto VG; Gershenwald JE; Johnson MM; Rimm DL; Bar-Eli M
Cancer Res; 2005 Dec; 65(23):11185-92. PubMed ID: 16322269
[TBL] [Abstract][Full Text] [Related]
19. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]